Farmak has changed the name for corticosteroid Betaspan Depo. Now, the pharmaceutical drug is named Depos. The dosage form remains without change that is suspension for injection, 1 ml, No. 5.
Depos is prescribed for the following diseases:
Dermatologic diseases
Atopic dermatitis (dermatitis nummularis), neurodermatitis, contact dermatitis, apparent solar dermatitis, Urticaria, lichen ruber planus, insulin lipodystrophy, Cazenave's vitiligo, discoid lupus erythematosus, psoriasis, cicatricial keloid, pemphigus, herpetic dermatitis, cystic comedones.
Rheumatic diseases
Rheumatoid arthritis, osteoarthritis, bursitis, tendinous synovitis, tendinitis, peritendinitis, ankylosing spondylitis, epicondylitis, radiculitis, coccygodynia, sciatica, lumbago, torticollis, ganglion cyst, exostosis, fasciitis, acute gouty arthritis, synovial cyst, metatarsalgia, cuboid bone inflammation, feet diseases, hard corn bursitis, eperon, hallux rigidus.
Allergic conditions
Bronchial asthma, status asthmaticus, hay fever, severe allergic bronchitis, seasonal and aperiodic allergic rhinitis, angioedema, contact dermatitis, atopic dermatitis, serum disease, reaction of high sensitivity to pharmaceutical drugs or insects’ bites.
Systemic lupus erythematosus, sclerodermia, dermatomyositis, periarteritis nodosa.
Oncological diseases
Palliative care of leukaemia and lymphoma in adult patients; acute leukaemia in children.
Other diseases
Androgenital syndrome. Ulcerative colitis, Crohn's disease, aphthous cachexia. Pathologic changes in blood requiring corticosteroid therapy. Nephritis, nephritic syndrome.
Primary and secondary insufficiency of cortex glandula suprarenalis (with mandatory simultaneous injection of mineralocorticoids).
